ABBOTT LABORATORIES Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31)
ABBOTT LABORATORIES (ABT) reported Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) of $32.69 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease · last filed 2012-11-07
- ABBOTT LABORATORIES other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2012-09-30 was $32.69M, a 15.70% increase year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $39.82M, a 74.61% increase year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $39.85M, a 33.67% increase year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$591.32M.
- ABBOTT LABORATORIES other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$510.44M.
- ABBOTT LABORATORIES other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2010 was -$59.45M.
- ABBOTT LABORATORIES other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2009 was -$259.81M.
- ABBOTT LABORATORIES other comprehensive income (loss), pension and other postretirement benefit plans, adjustment, net of tax (deprecated 2012-01-31) for fiscal 2008 was -$987.00M.
| Period end | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 3 month as first filed | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 6 month as first filed | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 9 month as first filed | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 12 month | Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax (Deprecated 2012-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $32.69M 10-Q · filed 2012-11-07 | $72.50M derived: sum of 2 quarters · filed 2012-11-07 | $112.36M 10-Q · filed 2012-11-07 | -$478.96M derived: sum of 4 quarters · filed 2012-11-07 | ||||
| 2012-06-30 | $39.82M 10-Q · filed 2012-08-07 | $79.67M 10-Q · filed 2012-08-07 | -$511.64M derived: sum of 3 quarters · filed 2012-08-07 | -$483.39M derived: sum of 4 quarters · filed 2012-11-07 | ||||
| 2012-03-31 | $39.85M 10-Q · filed 2012-05-08 | -$551.46M derived: sum of 2 quarters · filed 2012-05-08 | -$523.21M derived: sum of 3 quarters · filed 2012-11-07 | -$500.41M derived: sum of 4 quarters · filed 2012-11-07 | ||||
| 2011-12-31 | -$591.32M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | -$563.07M derived: sum of 2 quarters · filed 2012-11-07 | -$540.26M derived: sum of 3 quarters · filed 2012-11-07 | -$510.44M 10-K · filed 2012-02-21 | ||||
| 2011-09-30 | $28.25M 10-Q · filed 2012-11-07 | $28.00M 10-Q · filed 2011-11-04 | $51.05M derived: sum of 2 quarters · filed 2012-11-07 | $80.87M 10-Q · filed 2012-11-07 | $81.00M 10-Q · filed 2011-11-04 | $20.42M derived: sum of 4 quarters · filed 2012-11-07 | ||
| 2011-06-30 | $22.80M 10-Q · filed 2012-08-07 | $23.00M 10-Q · filed 2011-08-04 | $52.62M 10-Q · filed 2012-08-07 | $53.00M 10-Q · filed 2011-08-04 | -$7.83M derived: sum of 3 quarters · filed 2012-08-07 | -$3.83M derived: sum of 4 quarters · filed 2012-08-07 | ||
| 2011-03-31 | $29.82M 10-Q · filed 2012-05-08 | $30.00M 10-Q · filed 2011-05-06 | -$30.63M derived: sum of 2 quarters · filed 2012-05-08 | -$26.63M derived: sum of 3 quarters · filed 2012-05-08 | -$5.63M derived: sum of 4 quarters · filed 2012-05-08 | |||
| 2010-12-31 | -$60.45M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | -$56.45M derived: sum of 2 quarters · filed 2012-02-21 | -$35.45M derived: sum of 3 quarters · filed 2012-02-21 | -$59.45M 10-K · filed 2012-02-21 | -$59.00M 10-K · filed 2011-02-18 | |||
| 2010-09-30 | $4.00M 10-Q · filed 2011-11-04 | $20.00M 10-Q · filed 2010-11-05 | $25.00M derived: sum of 2 quarters · filed 2011-11-04 | $1.00M 10-Q · filed 2011-11-04 | $63.00M 10-Q · filed 2010-11-05 | -$250.81M derived: sum of 4 quarters · filed 2012-02-21 | ||
| 2010-06-30 | $21.00M 10-Q · filed 2011-08-04 | $43.00M 10-Q · filed 2011-08-04 | -$254.81M derived: sum of 3 quarters · filed 2012-02-21 | -$246.81M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $22.00M 10-Q · filed 2011-05-06 | -$275.81M derived: sum of 2 quarters · filed 2012-02-21 | -$267.81M derived: sum of 3 quarters · filed 2012-02-21 | -$253.81M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | -$297.81M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | -$289.81M derived: sum of 2 quarters · filed 2012-02-21 | -$275.81M derived: sum of 3 quarters · filed 2012-02-21 | -$259.81M 10-K · filed 2012-02-21 | -$260.00M 10-K · filed 2011-02-18 | |||
| 2009-09-30 | $8.00M 10-Q · filed 2010-11-05 | $22.00M derived: sum of 2 quarters · filed 2010-11-05 | $38.00M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $14.00M 10-Q · filed 2010-08-05 | $30.00M 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | -$987.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |